Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fowlie, P W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowlie, P W
Topic Collections
Right arrowRelated Article
Archives of Disease in Childhood Fetal and Neonatal Edition 2005;90:F190-FF190
© 2005 Archives of Disease in Childhood Fetal and Neonatal Edition


PERSPECTIVES

Patent ductus arteriosus

Managing the baby with a patent ductus arteriosus. More questions than answers?

P W Fowlie

Correspondence to:
Correspondence to:
Dr Fowlie
Neonatal Intensive Care Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK; peter.w.fowlie@tuht.scot.nhs.uk


There is no evidence that treatment of patent ductus arteriosus results in long term benefit

Keywords: patent ductus arteriosus; respiratory distress syndrome; long term outcome

The first 150 words of the full text of this article appear below.

Premature infants with a patent ductus arteriosus (PDA) are at increased risk of more prolonged and more severe respiratory distress syndrome, bronchopulmonary dysplasia, and death than similar infants whose ductuses have closed. In an attempt to improve the outcome for these infants, three broad strategies have been proposed: prophylactic "closure", closure of the asymptomatic but clinically detected PDA, and closure of the symptomatic PDA. Interventions, some of which have been subjected to more rigorous scrutiny than others, used as part of these strategies include fluid restriction, the use of diuretics, the use of cyclo-oxygenase inhibitors, and surgical closure using a variety of surgical techniques. There are now seven completed systematic reviews in the Cochrane library looking at such interventions.1 The bulk of the evidence available assesses the impact on short term outcomes, with some of the strategies resulting in, for example, an apparent decrease in the risk . . . [Full text of this article]


Related Article

Fantoms
Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2005 90: F189. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
S. Vanhaesebrouck, I. Zonnenberg, P. Vandervoort, E. Bruneel, M.-R. Van Hoestenberghe, and C. Theyskens
Conservative treatment for patent ductus arteriosus in the preterm
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F244 - F247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health